Instrument Inactif

Communiqués Sunesis Pharmaceuticals, Inc. Nasdaq

Actions

US8673286014

Communiqués

24/02/21	SUNESIS PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
24/02/21	SUNESIS PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
23/02/21	SUNESIS PHARMACEUTICALS INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
12/02/21	SUNESIS PHARMACEUTICALS INC : Other Events (form 8-K)	AQ
29/12/20	SUNESIS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Sunesis Pharmaceuticals, Inc. - SNSS	BU
22/12/20	SUNESIS PHARMACEUTICALS INC : Change in Directors or Principal Officers, Other Events (form 8-K)	AQ
03/12/20	SUNESIS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Sunesis Pharmaceuticals, Inc. - SNSS	BU
30/11/20	SUNESIS PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
30/11/20	Sunesis Pharmaceuticals and Viracta Therapeutics Announce Definitive Merger Agreement	GL
16/11/20	SUNESIS PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
16/11/20	Sunesis: 3Q Earnings Snapshot	AQ
16/11/20	Sunesis: 3Q Earnings Snapshot	AQ
16/11/20	Sunesis Pharmaceuticals : Reports Third Quarter 2020 Financial Results and Recent Highlights	AQ
16/11/20	Sunesis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Recent Highlights	GL
09/11/20	Sunesis Pharmaceuticals : to Host Conference Call on November 16th to Discuss Third Quarter 2020 Financial Results and Recent Highlights	AQ
09/11/20	Sunesis Pharmaceuticals to Host Conference Call on November 16th to Discuss Third Quarter 2020 Financial Results and Recent Highlights	GL
12/10/20	Sunesis Pharmaceuticals Announces Presentation of SNS-510 Preclinical Data at the 32nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics	GL
12/10/20	Sunesis Pharmaceuticals : Announces Presentation of SNS-510 Preclinical Data at the 32nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics	AQ
18/09/20	SUNESIS PHARMACEUTICALS INC : Other Events (form 8-K)	AQ
03/09/20	Sunesis Pharmaceuticals Announces Participation at Upcoming Investor Conferences	GL
02/09/20	SUNESIS PHARMACEUTICALS INC : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	AQ
02/09/20	Sunesis Pharmaceuticals Announces 1-for-10 Reverse Stock Split	GL
11/08/20	Sunesis: 2Q Earnings Snapshot	AQ
11/08/20	SUNESIS PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
11/08/20	Sunesis Pharmaceuticals Reports Second Quarter 2020 Financial Results and Recent Highlights	GL